Latest press releases
Global survey reveals heavy toll of COVID-19 first wave on liver cancer care
Digital Liver Cancer Summit 2021: A global survey assessing the impact of COVID-19 on liver cancer has revealed delays in the screening, diagnosis, and treatment of the disease, with experts issuing stark…
On World Cancer Day, EASL warmly welcomes Europe’s Beating Cancer Plan
4 February 2021 The month of February brings together several key actions to tackle cancer globally, and EASL is focussing particularly on the global threat of liver cancer. EASL draws on all…
Liver community fights liver cancer with a robust action plan
Digital Liver Cancer Summit 2021: As the latest data suggests, liver cancer is now the third-most deadly cancer in the world, claiming nearly 1 million lives in 2020, the liver community takes…
Significant improvements in mechanistic biomarkers of how Dialive™ improves organ function
About EASL and the ALIVER Consortium The ALIVER Consortium of 11 institutions from seven European countries developed an innovative liver dialysis machine called Dialive™. This device helps the liver to regenerate naturally…
Study identifies causes precipitating the most serious stage of cirrhosis
Researchers from EF Clif identify the causes that precipitate the onset of the most serious stage of cirrhosis: the syndrome of Acute-On-Chronic Liver Failure (ACLF). Barcelona, December 9, 2020 – A new investigation…
Muscle weakness and frailty adversely affect late-stage liver disease, study finds
AMRA Medical Research Results Support Strengthening Sarcopenia Guidelines AMRA Medical’s research publication in JHEP Reports details the link between MRI-based adverse muscle composition and NAFLD metabolic comordidity & poor function. Linköping, Sweden,…